🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ivo Shterev

Duke University

ORCID: 0000-0002-6804-2608

Also affiliated with Illumina (United States), Duke Medical Center, Duke University Hospital

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.694Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386
Top 29%
0.694DataRank
Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Papers

Driven by 5 papers — median percentile 0. Top paper: “Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)”.

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386
Top 29%
0.694DataRank
Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Long-Term Recovery of the Adaptive Immune System in Rhesus Macaques After Total Body Irradiation

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100677
N/A
0.489DataRank · unranked
25 citations

Matthew J. French, Brittany R. Sanders, Kristina J. Riebe, Ivo Shterev, Kevin Wiehe +7 more

Data from Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy

(2023)10.1158/1078-0432.c.6523037
N/A
0DataRank · unranked
0 citations

Eric R. Gamazon, Claudia Wing, Uchenna O. Njiaju, Chidiamara Njoku, Robert Michael Baldwin +15 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354.v1
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more